baber/WOPTO huggingface dataset:
Patent DE-69232791-T2 (DE)
Inventor: NISHI TOSHIYUKI
IPC: C07D/
Filed: 1992-06-19
Granted: 2003-05-15
Abstract: Known carbapenem derivatives such as thienamycin have disadvantages that they are physicochemically unstable and readily decomposed by enzymes such as DHP of the kidney to bring about adverse effects such as nephrotoxicity, while 1- beta - methylcarbapenem compounds are stable and have potent antibacterial activities but are yet unsatisfactory as regards the stability and antibacterial activity against DHP. Under these circumstances the invention provides an antibiotic represented by general formula (I) which has a potent antibacterial activity against various bacteria including Pseudomonas aeruginosa and is excellent in safety and stable against hydrolases such as DHP, and a salt thereof (I), wherein R<1> represents lower alkyl or optionally protected hydroxy lower alkyl; R<2>, R<1><3> and R<1><4> represent each hydrogen or lower alkyl; R<3> represents optionally esterified carboxy R<4>, R<9>, R<1><0> and R<1><5> represent each an amino-protective group, hydrogen or lower alkyl; R<5>, R<6>, R<1><1> and R<1><2> represent each hydrogen, hydroxyl, lower alkyl, hydroxy lower alkyl or halogen, or alternatively R<5> and R<6> and/or R<1><1> and R<1><2> may combine together to form alkylene; R<7> represents hydrogen, lower alkyl, carboxyl, carbamoyl or -CONR<7><1>R<7><2>; R<7><1> and R<7><2> represent each hydrogen or lower alkyl; R<8> represents hydrogen, lower alkyl or hydroxy lower alkyl, or alternatively R<8> may combine with R<7> to form alkylene; Z represents a single bond, oxygen, sulfur, -CR<1><1>R<1><2>-, -NR<1><3>CO-, -CONR<1><4>- or -NR<1><5>-; and m and n represent each an integer of 0 to 6. <CHEM>
Patent DE-69300400-T2 (DE)
Inventor: TAYLOR ROGER
IPC: B01J20/12
Filed: 1993-02-04
Granted: 1996-03-14
Abstract: An adsorbent material typically comprising an acid-treated three-layer mineral, such as a smectite clay mineral, having a silica content, expressed as SiO2, of from 90 % to 99.5 % by dry weight, an average pore diameter of 50 to 100 Angstroms, a non-water leachable aluminium content, expressed as Al2O3, of at least 0.05 % and a Hedley acidity of from 0.01 % to 4 % is provided. The adsorbent may be used to improve the haze resistance of aqueous beverages such as beers, wines, fruit extracts or fruit extract-containing beverages.
Patent DE-69309681-T2 (DE)
Inventor: VOYDEVILLE GILLES
IPC: A61B19/00
Filed: 1993-06-30
Granted: 1997-11-13
Abstract: PCT No. PCT/FR93/00664 Sec. 371 Date Feb. 8, 1995 Sec. 102(e) Date Feb. 8, 1995 PCT Filed Jun. 30, 1993 PCT Pub. No. WO94/01057 PCT Pub. Date Jan. 20, 1994A prosthesis including (a) a flexible ligament (1) with a first narrowed thinner portion (2) and a second wider portion (3) forming an extension of, and having a greater width and thickness (e2) than, the first portion, which portion may be passed around the spinous processes (12) of two adjacent vertebrae (L5, L4) in a figure eight pattern, whereas the second portion circles around the processes; (b) a semi-flexible interprocess block (6) with two pairs of through-channels (7, 8) having differing cross-sections and receiving the respective portions of the ligament; and (c) members (4, 5) for joining the ends of the ligament. The prosthesis prevents sagittal and frontal lumbar vertebral rotational instability.
Patent DE-69322513-T2 (DE)
Inventor: BERTIN AULIS
IPC: C03B27/04
Filed: 1993-06-11
Granted: 1999-05-27
Abstract: PCT No. PCT/FI93/00255 Sec. 371 Date Feb. 15, 1995 Sec. 102(e) Date Feb. 15, 1995 PCT Filed Jun. 11, 1993 PCT Pub. No. WO93/25487 PCT Pub. Date Dec. 23, 1993The invention relates to a method for the pre-treatment of coated glasses by removing the coating (2) from the edge areas (4) of the glass plate (1) and bevelling the areas from which the coating has been removed before heat treatment.
Patent DE-69330031-T2 (DE)
Inventor: KIMACHI KAZUHIKO
IPC: C07K16/00
Filed: 1993-11-25
Granted: 2001-07-19
Abstract: An anti-feline herpesvirus-1 recombinant antibody which is efficacious in treating, preventing and diagnosing feline herpesvirus-1 (FHV-1) infection, and a gene fragment useful for the preparation of the antibody. A gene fragment coding for the antibody V region bearing an FHV-1 specific avidity of a mouse monoclonal antibody having an excellent activity of neutralizing FHV-1 is obtained by constructing cells which produce the antibody. A chimeric anti-FHV-1 recombinant antibody is prepared from the above gene fragment and another gene fragment coding for a feline antibody C region. <IMAGE>
Patent DE-69331667-T2 (DE)
Inventor: OSHIMA MITSUAKI
IPC: H04N21/647
Filed: 1993-03-26
Granted: 2002-10-31
Abstract: At the transmitter side, carrier waves are modulated according to an input signal for producing relevant signal points in a signal space diagram. The input signal is divided into, two, first and second, data streams. The signal points are divided into signal point groups to which data of the first data stream are assigned. Also, data of the second data stream are assigned to the signal points of each signal point group. A difference in the transmission error rate between first and second data streams is developed by shifting the signal points to other positions in the space diagram. At the receiver side, the first and/or second data streams can be reconstructed from a received signal. In TV broadcast service, a TV signal is divided by a transmitter into, low and high, frequency band components which are designated as a first and a second data stream respectively. Upon receiving the TV signal, a receiver can reproduce only the low frequency band component or both the low and high frequency band components, depending on its capability.
Patent DE-69408525-T2 (DE)
Inventor: ANDERSON ELMER D
IPC: F27B21/06
Filed: 1994-08-25
Granted: 1998-06-18
Abstract: A process for consuming oily sludge waste product in steel making operations includes spraying a waste slurry onto the moving porous bed of a sinter strand. A burner hood is spaced above a portion of the moving bed. The bed carries a sinter mix which is ignited in the ignition zone of the burner hood and the slurry is sprayed onto the ignited sinter mix immediately downstream of the ignition zone. A vacuum system draws the slurry through the ignited sinter mix ensuring substantially complete combustion of the slurry.
Patent DE-69426572-T2 (DE)
Inventor: DENBY CARL
IPC: G01M3/32
Filed: 1994-10-07
Granted: 2001-08-23
Abstract: PCT No. PCT/GB94/02196 Sec. 371 Date Apr. 4, 1996 Sec. 102(e) Date Apr. 4, 1996 PCT Filed Oct. 7, 1994 PCT Pub. No. WO95/10033 PCT Pub. Date Apr. 13, 1995A method of testing the leakage rates from tanks for containing volatile liquids such as petrol or diesel, with a view to determining whether the tank leaks excessively. The tank is at least partially filled during testing in order to save time. The leakage is detected by sealing the tank and measuring the drop in pressure in the tank over a period of time. In order to measure the rate of leakage, a first measurement is taken during which an amount of 380 ml is removed from the tank over a short period whilst otherwise sealed, with the resultant pressure drop being measured as a calibrated value. The tank is then re-sealed and the pressure drop over the period of an hour is compared with the calibrated value.
Patent DE-69428035-T2 (DE)
Inventor: DILBER-VAN GRIETHUYSEN EVIN
IPC: A23L13/00
Filed: 1994-05-27
Granted: 2002-01-03
Abstract: A process for manufacturing cooked ham, comprising trimming and cutting pig muscles into pieces, treating said pieces with a high hydrostatic pressure, injecting brine into the pressure treated pieces of pig muscles, tumbling, filling, cooking and cooling them.
Patent DE-69428967-T2 (DE)
Inventor: JONASSON HALLGRIMUR
IPC: A61K9/107
Filed: 1994-07-01
Granted: 2002-04-04
Abstract: The present invention relates to novel oil-in-water emulsions especially suitable for parenteral administration of bioactive steroids which otherwise are difficult to solubilize in conventional solvents. The emulsions will comprise a lipid phase containing castor oil.
Patent DE-69501084-T2 (DE)
Inventor: TERRAT JEAN-PAUL
IPC: C23F15/00
Filed: 1995-02-01
Granted: 1998-07-02
Abstract: A salt bath compsn., contg. nitrate anions and sodium and opt. potassium cations, used at 320-550 degrees C for surface oxidn. of esp. nitrided ferrous metal parts to increase their corrosion resistance, includes 0.1-5 (pref. 0.5-1.75) wt.% lithium cations substituting sodium or potassium cations.
Patent DE-69507325-T2 (DE)
Inventor: KAUFMAN JOHN
IPC: A47K5/122
Filed: 1995-11-08
Granted: 1999-08-26
Abstract: Dispensers are provided of the type which include a flow path through which liquid must pass to leave the dispenser. After the dispenser has been actuated to dispense, the flow path then receives reverse flow as the dispenser recovers ready for the next dispensing. This reverse flow limits the possibility of dripping from the dispensing outlet. A flow controller in the flow path automatically adjusts to have little or no interference to the flow of liquid leaving the dispenser and then positions itself to slow down the rate of reverse flow into the dispenser. The dispenser is suitable for more viscous liquids.
Patent DE-69509103-T2 (DE)
Inventor: LANGEDIJK JOHANNES PETRUS MARI
IPC: C12P21/08
Filed: 1995-08-22
Granted: 1999-09-30
Abstract: PCT No. PCT/NL95/00279 Sec. 371 Date Feb. 25, 1997 Sec. 102(e) Date Feb. 25, 1997 PCT Filed Aug. 22, 1995 PCT Pub. No. WO96/06112 PCT Pub. Date Feb. 29, 1996Antigenic substance or precursor thereof comprising a peptide part derived from an amino acid sequence located between two mucin-like regions of a protein G of a respiratory syncytial virus (RSV). Said andgenic substance or precursor thereof allows to discriminate between, or identify, different types or subtypes of respiratory syncytial viruses, or antibodies against them. In preferred embodiments, the peptide part is derived from protein G of bovine respiratory syncytial virus, human respiratory syncytial virus A, human respiratory syncytial virus B, or ovine respiratory syncytial virus. Use of the antigenic substance or precursor thereof (in vaccines) for prophylaxis of RSV infections, in assays and testkits for detecting or identifying (antibodies against) RSV types or subtypes, and in methods for obtaining antibodies against RSV types or subtypes. Use of such antibodies in assays and testkits for detecting or identifying RSV types or subtypes.
Patent DE-69511984-T2 (DE)
Inventor: LEGRAND HUGUES
IPC: B22D11/06
Filed: 1995-10-06
Granted: 2000-05-18
Abstract: The ingot mould, e.g. for molten steel, consists of two cooled rollers (2) set with a gap between them forming the moulding surface. Each of the rollers has a series of circular or elliptical recesses (7-10) formed by surface lobes (3-6). The lobed surface has a perimeter which is 1.1-1.5 times greater than an equivalent roller with a cylindrical surface.
Patent DE-69514646-T2 (DE)
Inventor: UWA MARIAN
IPC: B07B1/22
Filed: 1995-05-05
Granted: 2000-06-08
Abstract: The machine consists of a horizontal or slightly inclined rotary drum (10) made up of a number of sections (10a - 10e) with apertures (26) increasing in size in the direction of the flow through the drum. Each drum section has a truncated conical wall which converges in the direction of the flow, with the apertures in the shape of slots of increasing size in the same direction. Each drum section is in the form of a separate module which can be detached from the adjacent sections, to which it is connected by bolted flanges (14, 16). The end flanges of the first and last drum sections are supported by roller bearings (18, 20). The inside of each drum section has guide vanes, and the slots are inclined relative to the direction of travel.
Patent DE-69523604-T2 (DE)
Inventor: BONAVENTURA JOSEPH
IPC: C07K14/795
Filed: 1995-07-07
Granted: 2002-04-25
Abstract: The invention is directed to human serum albumin-porphyrin (HSA-P) complexes which are capable of reversible oxygen binding and their uses. These complexes may be used in applications requiring physiological oxygen carriers such as in blood substitute solutions, or in applications requiring plasma expanders. Methods for the production of these complexes are provided. In a specific example, HSA-P complexes are shown to exhibit reversible oxygen binding. In another example, the HSA-P complex does not exhibit appreciable vasoactivity.
Patent DE-69524966-T2 (DE)
Inventor: PFAENDNER RUDOLF
IPC: C08G69/06
Filed: 1995-10-05
Granted: 2002-08-29
Abstract: PCT No. PCT/EP95/03937 Sec. 371 Date Apr. 9, 1997 Sec. 102(e) Date Apr. 9, 1997 PCT Filed Oct. 5, 1995 PCT Pub. No. WO96/11978 PCT Pub. Date Apr. 25, 1996The invention relates to a process for increasing the molecular weight of polycondensates, which comprises heating a polycondensate in the temperature range below the melting point and above the glass transition temperature in the solid phase of the polymer with additionof at least one sterically hindered hydroxyphenylalkylphosphonic ester or monoester.
Patent DE-69526595-T2 (DE)
Inventor: SAKAMOTO MASATO
IPC: B01D39/16
Filed: 1995-02-02
Granted: 2002-08-22
Abstract: This invention relates to bicyclic amino group-substituted pyridonecarboxylic acid derivatives of the general formula A-Pri, esters thereof and salts thereof, wherein:     Pri is a pyridonecarboxylic acid residue, and A is a bicyclic amino group represented by the following formula and joined to the 7-position of the pyridonecarboxylic acid or a position equivalent to the 7-position thereof.   <CHEM> wherein R1 and R2 may be the same or different and each represents a hydrogen atom, a lower alkyl group or an amino-protecting group; R3 and R4 may be the same or different and each represents a hydrogen atom, a halogen atom, a cyano group, a hydroxyl group, an oxo group, a lower alkoxy group or a lower alkyl group; and n is an integer of 0 or 1. The above-described pyridonecarboxylic acid derivatives, esters thereof and salts thereof are useful as antibacterial agents. This invention also relates to bicyclic amine compounds useful as direct intermediates for the synthesis of the above-described pyridonecarboxylic acid derivatives.
Patent DE-69529678-T2 (DE)
Inventor: DEUTSCH J
IPC: C07D277/22
Filed: 1995-08-07
Granted: 2003-09-25
Abstract: The combination of the HIV protease inhibitor Compound J and any one or more of four other potent HIV protease inhibitors is useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.
Patent DE-69531597-T2 (DE)
Inventor: SACHDEV MANOJ
IPC: G01R31/28
Filed: 1995-06-29
Granted: 2004-06-24
Abstract: A flipflop has master and slave interconnected through a buffer. The master has its inverters located outside the signal path from input to output, as the buffer provides the driving capability required for both IDDQ-testing and operational use. This configuration enables IDDQ-testing without further circuitry added to the flipflop and reduces propagation delay in the signal path.
Patent DE-69534507-T2 (DE)
Inventor: CHEUNG TIN-TACK PETER
IPC: B01J23/58
Filed: 1995-07-18
Granted: 2006-07-27
Abstract: Selective hydrogenation process for (4-10)C diolefins with hydrogen gas comprises: (a) at least one palladium-contg. material selected from Pd or Pd-oxide; (b) at least one silver-contg. material selected from Ag and AgO; (c) at least one alkali metal fluoride; and (d) at least one inorganic support material. The inorganic support is pref. alumina, silica, titania, zirconia, aluminosilicate, zinc aluminate and/or zinc titanate. The alkali metal fluoride is pref. potassium fluoride and the support pref. alumina. The catalyst pref. includes 0.05 - 0.6 wt.% Pd, 0.1 - 5 wt.% Ag and 0.2 - 5 wt.% alkali metal. The wt. ratio of Ag:Pd is pref. 2:1 - 10:1. The catalyst pref. comprises particles of size 1-10 nm and surface area 1 - 200 m2/g. The catalyst is pref. made by impregnating a solid material of (a), (b) and (d) with a soln. comprising at least one alkali metal fluoride, drying the impregnated solid material and calcining it at 300 - 600[deg]C. The diolefins and monoolefins are pref. (4-6)C. At least one diolefin is pref. 1.3-butadiene. The feed pref. contains butenes and 0.01-10 wt. % 1,3-butadiene. The feed pref. additionally includes at least one impurity selected from H2S, mercaptans, organic sulphides and CO. 1 - 2 moles of H2 are pref. used per mole of 1,3-butadiene in the feed. The liq. hourly space velocity of the feed is pref. 3 - 100 litres per litre catalyst compsn. per hour. The reaction temp. is pref. 35 - 100[deg]C and pressure 50 - 1000 psig.
Patent DE-69600272-T2 (DE)
Inventor: FUJIWARA JUNYA
IPC: C07D215/52
Filed: 1996-02-08
Granted: 1998-09-17
Abstract: The present invention relates to quinoline-4-carbonylguanidine derivative represented by formula (1) <CHEM> and pharmaceutically acceptable salt thereof, a process for producing the same, and a Na<+>/H<+> exchanger inhibitor containing the compound as an active ingredient. The compounds of the present invention are useful as an agent for treating or preventing various diseases by hyperfunction of the Na<+>/H<+> exchanger and as a diagnostic agent for these diseases.
Patent DE-69602846-T2 (DE)
Inventor: BALLIN FELICE
IPC: B21C1/30
Filed: 1996-07-12
Granted: 1999-11-25
Abstract: PCT No. PCT/EP96/03067 Sec. 371 Date Jun. 3, 1998 Sec. 102(e) Date Jun. 3, 1998 PCT Filed Jul. 12, 1996 PCT Pub. No. WO97/05972 PCT Pub. Date Feb. 20, 1997According to the invention, a drawing carriage is made to execute a forward stroke and a return stroke alternately, along longitudinal guides on a drawing bench, between two opposite drawing heads, each disposed in one end area of the said bench and each including at least one draw plate, by means of driving horizontally with a reciprocating motion. At least one piece to be drawn is pulled in each forward stroke and in each return stroke by the said drawing carriage, being made to pass through a corresponding draw plate in the drawing head from which the said carriage is made to move away. In this way, the carriage executes working strokes in both directions of horizontal movement along the corresponding guides, causing at least one piece to be drawn in each working stroke.
Patent DE-69603538-T2 (DE)
Inventor: BABIN DENIS L
IPC: B29C45/26
Filed: 1996-05-10
Granted: 1999-11-25
Abstract: Injection molding apparatus for side gating to several cavities spaced around a central heated nozzle (10) extending through an opening (12) in the mold. Several side gate seals (24) are seated in a front portion of the nozzle, each in alignment between one of several radial portions (76) of a melt channel (56) through the nozzle and a gate (18) leading to one of the cavities. The side gate seals (24) each have an outer end (80) which extends a sufficient distance outwardly past the inner surface (72) of the opening (12) in the mold to provide room for cooling conduits (40) extending between the cavities and the central opening. The side gate seals (24) are mounted after the nozzle is sealed in the opening in the mold. A gate insert (22) is then mounted radially into position over the outer end (80) of each side gate seal (24). A gate insert retainer plate (96) secures the gate inserts (22) in place. <IMAGE>
Patent DE-69608753-T2 (DE)
Inventor: FREDERIKSEN BJARNE
IPC: F24D19/10
Filed: 1996-09-12
Granted: 2000-11-23
Abstract: A radiator thermostat element (1) is disclosed, having a housing and a pressure chamber (2) arranged therein, which pressure chamber is enclosed by a capsule (3) and into which a corrugated tube (11) biased by a spring (15) projects. In such a thermostat element it is desirable to construct a safety device so that it can be mounted simply and with low undesirable variations. For that purpose, inside the corrugated tube (11) there is arranged a plunger (13) on which the spring (15) acts and which bears with one end against the base (14) of the corrugated tube. Further, between the other end of the plunger (13) and the spring (15) there is clamped a retaining element (18) which is arranged in a seat (19) in a housing element (7). <IMAGE>
Patent DE-69610535-T2 (DE)
Inventor: COUTU LUCIEN
IPC: C22F1/10
Filed: 1996-06-20
Granted: 2001-06-07
Abstract: Alloy is used to make a mask for use inside a cathode ray tube and comprises 69-83 wt.% Ni, and up to the following amounts of other elements with the residue being Fe: 7% Mo, 8% Cu, 1.5% Co, 7% W, 7% Nb, 7% V, 7% Cr, 7% Ta, 0.1% C, 1% Mn, 1% Si, 1.2% Ti, 1.2% Al, 1.2% Zr, 1.2% Hf and 0.010% S. The following equations also restrict the percentages: Co+Ni+1.5 x Cu ≥ 79.5%; 3 x (Co+Ni)-2 x Cu ≥ 206%; Co+Ni+7 x Cu ≤ 130%; 7 x(Co+Ni)+2 x Cu ≤ 581%; Mo+W+Nb+V+Cr+Ta ≤ 7%; Ti+Al+Zr+Hf ≤ 1.2%; C+Mn+Si ≤ 1%; 80.5 ≤ Co+Ni+0.80 x Cu ≤ 81.7%. The mask is also claimed.
Patent DE-69616344-T2 (DE)
Inventor: AFFINITO JOHN D
IPC: C23C14/24
Filed: 1996-07-25
Granted: 2002-07-11
Abstract: A method for fabrication of polymer composite layers in a vacuum is disclosed. More specifically, the method of dissolving salts in a monomer solution, vacuum flash evaporating the solution, condensing the flash evaporated solution as a liquid film, and forming the condensed liquid film into a polymer composite layer on a substrate is disclosed.
Patent DE-69617234-T2 (DE)
Inventor: KOIVISTO AULIS
IPC: F16H25/22
Filed: 1996-06-05
Granted: 2002-06-13
Abstract: PCT No. PCT/FI96/00335 Sec. 371 Date Dec. 4, 1997 Sec. 102(e) Date Dec. 4, 1997 PCT Filed Jun. 5, 1996 PCT Pub. No. WO96/39590 PCT Pub. Date Dec. 12, 1996An actuator for creating linear movement is provided. The actuator includes a motor having a rotatable motor axle. As the rotatable motor axle rotates, it uses internal threads to transfer rotational motion to external threads of a movement axle. By transferring the rotational motion of motor axle to the movement axle, the motor's rotating movement is changed into linear movement. This linear movement can then used for moving a frequency control element such as those used in filters, which are in-turn used in the base station of a cellular radio network.
Patent DE-69629766-T2 (DE)
Inventor: HORST ROBERT W
IPC: H04L69/40
Filed: 1996-06-06
Granted: 2004-07-15
Abstract: A multiprocessor system includes a number of sub-processor systems, each substantially identically constructed, and each comprising a central processing unit (CPU), and at least one I/O device, interconnected by routing apparatus that also interconnects the sub-processor systems. A CPU of any one of the sub-processor systems may communicate, through the routing elements, with any I/O device of the system, or with any CPU of the system. Communications between I/O devices and CPUs is by packetized messages. Interrupts from I/O devices are communicated from the I/O devices to the CPUs (or from one CPU to another CPU) as message packets. CPUs and I/O devices may write to, or read from, memory of a CPU of the system. Memory protection is provided by an access validation method maintained by each CPU in which CPUs and/or I/O devices are provided with a validation to read/write memory of that CPU, without which memory access is denied. <IMAGE>   <IMAGE>
Patent DE-69632395-T2 (DE)
Inventor: MANNINO RAPHAEL JAMES
IPC: A61K38/21
Filed: 1996-02-22
Granted: 2005-05-04
Abstract: The instant disclosure relates to cochleates comprising a) a biologically relevant molecule component b) a negatively charged lipid component, and c) a divalent cation component. The cochleate has an extended shelf life, even in a desiccated state. Advantageously, the cochleate can be ingested. The biologically relevant molecule can be a polynucleotide.